Cancer

A Stanford Medicine-designed molecule turns BCL6, a protein that helps drive lymphoma, into a trigger for cancer-cell death.

Clinical assistant professor Kathryne Sanserino explains why menopause can be especially intense after breast cancer treatment and how personalized, nonhormonal treatment options can help.

The FDA finally gave the green light to bemotrizinol. Stanford Medicine experts share why it’s considered a massive leap forward for skin health in the U.S.

Colorectal cancer is now the No. 1 cause of cancer deaths among people under age 50. Here’s what Stanford Medicine experts want you to know.

Cellular and molecular interactions around tumors give insight into their structures and weaknesses, but measuring them has been expensive and slow. A Stanford Medicine AI platform flips the script.

Taking inspiration from biology, Stanford researchers developed a CAR-T cell design that improved tumor control in mice.

Antibody therapies show limited success in solid tumors. A new Stanford Medicine imaging method, precise enough to locate antibodies at subcellular resolution, hints at why.

Modulating a molecular seesaw could reduce inflammation, aid wound healing, and curb skin cancer growth.

A new drug is doubling survival times for one of the deadliest cancers. Stanford Medicine’s Daniel Delitto breaks down how it works and what else is on the horizon.

A proposed cancer center in Redwood City would combine care and research to advance treatments for a growing patient population.